Transcription of Pharmacy and Therapeutics Committee-approved …
{{id}} {{{paragraph}}}
Pharmacy and Therapeutics Committee-approvedTherapeutic InterchangesTherapeutic InterchangeRevision DateAlpha Blockers08/11 Alpha Reductase Inhibitors05/16 ACE Inhibitors08/11 Angiotensin Receptor Blockers08/11 Buprenorphine09/11 Calcium Channel Blockers (DHP)08/11 Carbapenems07/11 Cardioselective Beta Blockers08/11 Cephalosporins09/11 Corticosteroids, Inhaled06/16 Corticosteroids, Intranasal08/11 Fluoroquinolones01/13 Glitazones08/11 Histamine Receptor Antagonists (H2 RAs)08/11 Inhaled Anticholinergics05/16 Insulin Analogs05/16IV to PO conversions05/16 Leukotriene Receptor Antagonists08/11 Levalbuterol12/13 Miscellaneous Antidepressants05/16 Miscellaneous CNS Stimulants05/16 Nitroglycerin Sublingual05/16 Non-benzodiazepine Hypnotics08/11 Non-sedating Antihistamines08/11 Ophthalmic Preparations08/11 Phosphate Binders01/13 Proton Pump Inhbitors08/11 Statins08/11 All conversions unless noted otherwise are for adult patients with normal renal and/or hepatic function.
Pharmacy and Therapeutics Committee-approved Therapeutic Interchanges Therapeutic Interchange Revision Date Alpha Blockers …
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}